232 related articles for article (PubMed ID: 34572541)
1. Novel Approaches to an Integrated Route for Trisomy 21 Evaluation.
Buczyńska A; Sidorkiewicz I; Trochimiuk A; Ławicki S; Krętowski AJ; Zbucka-Krętowska M
Biomolecules; 2021 Sep; 11(9):. PubMed ID: 34572541
[TBL] [Abstract][Full Text] [Related]
2. Prenatal screening for fetal aneuploidy in singleton pregnancies.
Chitayat D; Langlois S; Douglas Wilson R; ;
J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
[TBL] [Abstract][Full Text] [Related]
3. Clinical performance of non-invasive prenatal served as a first-tier screening test for trisomy 21, 18, 13 and sex chromosome aneuploidy in a pilot city in China.
Liu Y; Liu H; He Y; Xu W; Ma Q; He Y; Lei W; Chen G; He Z; Huang J; Liu J; Liu Y; Huang Q; Yu F
Hum Genomics; 2020 Jun; 14(1):21. PubMed ID: 32503639
[TBL] [Abstract][Full Text] [Related]
4. The consequences of implementing non-invasive prenatal testing in Dutch national health care: a cost-effectiveness analysis.
Beulen L; Grutters JP; Faas BH; Feenstra I; van Vugt JM; Bekker MN
Eur J Obstet Gynecol Reprod Biol; 2014 Nov; 182():53-61. PubMed ID: 25238658
[TBL] [Abstract][Full Text] [Related]
5. Prenatal diagnostic testing and atypical chromosome abnormalities following combined first-trimester screening: implications for contingent models of non-invasive prenatal testing.
Lindquist A; Poulton A; Halliday J; Hui L
Ultrasound Obstet Gynecol; 2018 Apr; 51(4):487-492. PubMed ID: 29226487
[TBL] [Abstract][Full Text] [Related]
6. Analysis of cell-free fetal DNA in maternal blood for detection of trisomy 21, 18 and 13 in a general pregnant population and in a high risk population - a systematic review and meta-analysis.
Iwarsson E; Jacobsson B; Dagerhamn J; Davidson T; Bernabé E; Heibert Arnlind M
Acta Obstet Gynecol Scand; 2017 Jan; 96(1):7-18. PubMed ID: 27779757
[TBL] [Abstract][Full Text] [Related]
7. Clinical experience from Thailand: noninvasive prenatal testing as screening tests for trisomies 21, 18 and 13 in 4736 pregnancies.
Manotaya S; Xu H; Uerpairojkit B; Chen F; Charoenvidhya D; Liu H; Petcharaburanin N; Liu Y; Tang S; Wang X; Dansakul S; Thomsopa T; Gao Y; Zhang H; Xu H; Jiang H
Prenat Diagn; 2016 Mar; 36(3):224-31. PubMed ID: 26748603
[TBL] [Abstract][Full Text] [Related]
8. Application of Differentially Methylated Loci in Clinical Diagnosis of Trisomy 21 Syndrome.
Zhang R; Yin Y; Zhang S; Chen L; Pu L; Deng Q; Zhang H; Xiao L
Genet Test Mol Biomarkers; 2019 Apr; 23(4):246-250. PubMed ID: 30986102
[TBL] [Abstract][Full Text] [Related]
9. Non-invasive prenatal testing for aneuploidy: current status and future prospects.
Benn P; Cuckle H; Pergament E
Ultrasound Obstet Gynecol; 2013 Jul; 42(1):15-33. PubMed ID: 23765643
[TBL] [Abstract][Full Text] [Related]
10. Ten-year trends in prevalence of Down syndrome in a developing country: impact of the maternal age and prenatal screening.
Kurtovic-Kozaric A; Mehinovic L; Malesevic R; Mesanovic S; Jaros T; Stomornjak-Vukadin M; Mackic-Djurovic M; Ibrulj S; Kurtovic-Basic I; Kozaric M
Eur J Obstet Gynecol Reprod Biol; 2016 Nov; 206():79-83. PubMed ID: 27639605
[TBL] [Abstract][Full Text] [Related]
11. Impact of prenatal screening on the prevalence of Down syndrome in Slovenia.
Rudolf G; Tul N; Verdenik I; Volk M; Brezigar A; Kokalj Vokač N; Jeršin N; Prosenc B; Premru Sršen T; Peterlin B
PLoS One; 2017; 12(6):e0180348. PubMed ID: 28665986
[TBL] [Abstract][Full Text] [Related]
12. [CLINICAL IMPLEMENTATION OF CELL-FREE DNA ANALYSIS IN MATERNAL BLOOD IN SCREENING FOR ANEUPLOIDIES IN SINGLETON PREGNANCIES].
Chaveeva P; Yankova M; Stratieva V; Dimitrov I; Shterev A
Akush Ginekol (Sofiia); 2016; 55(2):10-5. PubMed ID: 27509651
[TBL] [Abstract][Full Text] [Related]
13. Contingent first-trimester screening for aneuploidies with cell-free DNA in a Danish clinical setting.
Miltoft CB; Rode L; Ekelund CK; Sundberg K; Kjaergaard S; Zingenberg H; Tabor A
Ultrasound Obstet Gynecol; 2018 Apr; 51(4):470-479. PubMed ID: 28640470
[TBL] [Abstract][Full Text] [Related]
14. Population-based trends in prenatal screening and diagnosis for aneuploidy: a retrospective analysis of 38 years of state-wide data.
Hui L; Muggli EE; Halliday JL
BJOG; 2016 Jan; 123(1):90-7. PubMed ID: 26108969
[TBL] [Abstract][Full Text] [Related]
15. Novel Epigenetic Markers on Chromosome 21 for Noninvasive Prenatal Testing of Fetal Trisomy 21.
Lee DE; Lim JH; Kim MH; Park SY; Ryu HM
J Mol Diagn; 2016 May; 18(3):378-387. PubMed ID: 26947512
[TBL] [Abstract][Full Text] [Related]
16. Disease specific characteristics of fetal epigenetic markers for non-invasive prenatal testing of trisomy 21.
Lim JH; Lee DE; Park SY; Kim DJ; Ahn HK; Han YJ; Kim MY; Ryu HM
BMC Med Genomics; 2014 Jan; 7():1. PubMed ID: 24397966
[TBL] [Abstract][Full Text] [Related]
17. Prenatal reflex DNA screening for trisomy 21, 18 and 13.
Wald NJ
Expert Rev Mol Diagn; 2018 May; 18(5):399-401. PubMed ID: 29633889
[No Abstract] [Full Text] [Related]
18. [Value of detection of cell-free fetal DNA in maternal plasma in the prenatal diagnosis of chromosomal abnormalities].
Wang SJ; Gao ZY; Lu YP; Li YL; You YQ; Zhang LW; Wang LX; Xu H
Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):808-12. PubMed ID: 23302119
[TBL] [Abstract][Full Text] [Related]
19. [Genetics, diagnosis and characteristics of trisomy 21].
Ravel A
Soins Pediatr Pueric; 2018; 39(302):10-14. PubMed ID: 29747764
[TBL] [Abstract][Full Text] [Related]
20. Positive predictive value estimates for cell-free noninvasive prenatal screening from data of a large referral genetic diagnostic laboratory.
Petersen AK; Cheung SW; Smith JL; Bi W; Ward PA; Peacock S; Braxton A; Van Den Veyver IB; Breman AM
Am J Obstet Gynecol; 2017 Dec; 217(6):691.e1-691.e6. PubMed ID: 29032050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
